Advanced search
Publication Cover
Renal Failure Volume 35, 2013 - Issue 1
Submit an article Journal homepage
540
Views
2
CrossRef citations to date
0
Altmetric
Clinical Study

Expression of Both Matrix Metalloproteinase-2 and Its Tissue Inhibitor-2 in Tunica Media of Radial Artery in Uremic Patients

Aiqin ShanDepartment of Nephrology, Ningbo Yinzhou People’s Hospital, Zhejiang Province, Ningbo, China
,
Canxin ZhouDepartment of Nephrology, Ningbo Yinzhou People’s Hospital, Zhejiang Province, Ningbo, ChinaCorrespondence[email protected]
,
Yongping HeDepartment of Nephrology, Ningbo Yinzhou People’s Hospital, Zhejiang Province, Ningbo, China
,
Weisheng FengDepartment of Nephrology, Ningbo Yinzhou People’s Hospital, Zhejiang Province, Ningbo, China
,
Gun ChenDepartment of Pathology, Ningbo Yinzhou People’s Hospital, Zhejiang Province, Ningbo, China
&
Guoping ZhongDepartment of Pathology, Ningbo Yinzhou People’s Hospital, Zhejiang Province, Ningbo, China
Pages 37-42 | Received 04 Jul 2012, Accepted 04 Oct 2012, Published online: 14 Nov 2012

REFERENCES

  • Pai A, Leaf EM, El-Abbadi M, . Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcification in a uremic mouse model of chronic kidney disease. Am J Pathol. 2011;178:764–773.
  • Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006; 69:562–573.
  • Moe SM, O’Neill KD, Duan D, . Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int. 2002;61:638–647.
  • Ossareh S. Vascular calcification in chronic kidney disease: mechanisms and clinical implications. Iran J Kidney Dis. 2011;5:285–299.
  • Guérin AP, Pannier B, Métivier F, . Assessment and significance of arterial stiffness in patients with chronic kidney disease. Curr Opin Nephrol Hypertens. 2008;17:635–641.
  • Johnson RC, Leopold JA, Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res. 2006;99:1044–1059.
  • Mizobuchi M, Towler D, Slatopolsky E. Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol. 2009;20:1453–1464.
  • Sage AP, Tintut Y, Demer LL. Regulatory mechanisms in vascular calcification. Nat Rev Cardiol. 2010;7:528–536.
  • Chung AW, Yang HH, Kim JM, . Upregulation of matrix metalloproteinase-2 in the arterial vasculature contributes to stiffening and vasomotor dysfunction in patients with chronic kidney disease. Circulation. 2009;120:792–801.
  • Kumata C, Mizobuchi M, Ogata H, . Involvement of matrix metalloproteinase-2 in the development of medial layer vascular calcification in uremic rats. Ther Apher Dial. 2011;15:18–22.
  • Basalyga DM, Simionescu DT, Xiong W, . Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinases. Circulation. 2004;110:3480–3487.
  • Qin X, Corriere MA, Matrisian LM, . Matrix metalloproteinase inhibition attenuates aortic calcification. Arterioscler Thromb Vasc Biol. 2006;26:1510–1516.
  • Mesquita M, Demulder A, Wolff F, . Osteoprotegerin and progression of coronary and aortic calcifications in chronic kidney disease. Transplant Proc. 2010;42:3444–3449.
  • Kurnatowska I, Grzelak P, Kaczmarska M, . Serum osteoprotegerin is a predictor of progression of atherosclerosis and coronary calcification in hemodialysis patients. Nephron Clin Pract. 2011;117:297–304.
  • Shao JS, Sierra OL, Cohen R, . Vascular calcification and aortic fibrosis: a bifunctional role for osteopontin in diabetic arteriosclerosis. Arterioscler Thromb Vasc Biol. 2011;31:1821–1833.
  • Mecham RP, Kovacs A, Wang J, . Circulating levels of osteopontin are related with calcification parameters in patients with renal transplantations. Transplant Proc. 2011;43:562–564.
  • Rezg R, Barreto FC, Barreto DV, . Inhibitors of vascular calcification as potential therapeutic targets. J Nephrol. 2011;24:416–427.
  • Valdivielso JM. Vascular calcification: types and mechanisms. Nefrologia. 2011;31:142–147.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.